The results of a clinical and neurophysiological study of the effectiveness of Parkon spray in the treatment of Parkinson’s Disease (PD)

Autor: BM Gekht, NI Goldstein

Publikováno v: Open Journal of Parkinson's Disease and Treatment. 5:001-003

For more than 25 years, we have begun an experimental study of the physiological effect of micromolar concentrations of reactive oxygen species on the regulatory functions of the central nervous system. We found that these effects extend to the CNS c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5f2debb9da5d589d7b8f0d7fdf55f50
https://doi.org/10.17352/ojpdt.000012

CCR 20th anniversary commentary: a chimeric antibody, C225, inhibits EGFR activation and tumor growth.

Autor: Mendelsohn J; The University of Texas MD Anderson Cancer Center, Houston, Texas. jmendelsohn@mdanderson.org., Prewett M; Eli Lilly and Company, Indianapolis, Indiana., Rockwell P; Hunter College, City University of New York, New York, New York., Goldstein NI; Helio Genetics, East Hanover, New Jersey.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Jan 15; Vol. 21 (2), pp. 227-9.

Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules.

Autor: Goldstein NI; Antyra, Inc., Edison, NJ, USA., Fisher PB

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2007; Vol. 383, pp. 245-58.

Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks.

Autor: Schäffer L; Novo Nordisk AS, DK-2800 Bagsvaerd, Denmark. lsc@novonordisk.com, Brissette RE, Spetzler JC, Pillutla RC, Østergaard S, Lennick M, Brandt J, Fletcher PW, Danielsen GM, Hsiao KC, Andersen AS, Dedova O, Ribel U, Hoeg-Jensen T, Hansen PH, Blume AJ, Markussen J, Goldstein NI

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2003 Apr 15; Vol. 100 (8), pp. 4435-9. Date of Electronic Publication: 2003 Apr 08.

Target validation and drug discovery using genomic and protein-protein interaction technologies.

Autor: Pillutla RC; DGI Biotechnologies, Inc. 40 Talmadge Road, Edison, NJ 08818, USA., Fisher PB, Blume AJ, Goldstein NI

Publikováno v: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2002 Aug; Vol. 6 (4), pp. 517-31.